Multi-disciplinary Care for Brain Metastases
Intensive Multi-Disciplinary Care Initiative for Patients With Newly Diagnosed Brain Metastases
1 other identifier
interventional
40
1 country
1
Brief Summary
This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 16, 2023
CompletedFirst Submitted
Initial submission to the registry
February 19, 2024
CompletedFirst Posted
Study publicly available on registry
February 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
January 29, 2026
December 1, 2025
3.1 years
February 19, 2024
January 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Patient reported outcomes
Symptom burden based on patient reporting on Brain Mets Symptom Inventory
6-12 months
Secondary Outcomes (3)
Feasibility
6-12 months
Patient understanding of prognosis
6-12 months
survival
6-12 months
Other Outcomes (1)
Exploratory survival outcome
6-12 months
Study Arms (2)
Standard of Care
ACTIVE COMPARATORMultidisciplinary Care
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Patients of all genders must be at least 18 years of age.
- Patients must have histologically confirmed, newly diagnosed brain metastases from known or suspected solid tumor primary neoplasms.
- Patients must be able to accurately provide self-report data (e.g. per clinical judgment, cognitive function is intact).
- Patients must be able to complete questionnaires in English.
- Patients must have the ability to provide informed consent.
You may not qualify if:
- Patients who are \< 18 years of age are not eligible.
- Patients who are Pregnant are not eligible.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Vermont Medical Center
Burlington, Vermont, 05401, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Neurological Sciences
Study Record Dates
First Submitted
February 19, 2024
First Posted
February 28, 2024
Study Start
November 16, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
July 1, 2027
Last Updated
January 29, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share